F1063-0967

CAS No. 613225-56-2

F1063-0967 ( F1063-0967 )

Catalog No. M18899 CAS No. 613225-56-2

F1063-0967 is a Dual-specificity phosphatase 26 (DUSP26) inhibitor with an IC50 of 11.62 μM.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 27 In Stock
5MG 41 In Stock
10MG 67 In Stock
50MG 177 In Stock
100MG 259 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    F1063-0967
  • Note
    Research use only, not for human use.
  • Brief Description
    F1063-0967 is a Dual-specificity phosphatase 26 (DUSP26) inhibitor with an IC50 of 11.62 μM.
  • Description
    F1063-0967 is a novel inhibitor of dual-specificity phosphatase 26 (DUSP26), inducing apoptosis in IMR-32 cell line.
  • Synonyms
    F1063-0967
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    DUSP26
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    613225-56-2
  • Formula Weight
    484.59
  • Molecular Formula
    C24H24N2O5S2
  • Purity
    98%
  • Solubility
    DMSO : 125 mg/mL 257.95 mM;
  • SMILES
    S=C3S\C(=C/c1ccc(C)cc1)C(=O)N3CCCCCC(=O)Nc2ccc(C(=O)O)c(O)c2
  • Chemical Name
    (Z)-2-Hydroxy-4-{6-[5-(4-methyl-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-hexanoylamino}-benzoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ren JX, et al. Identification of novel dual-specificity phosphatase 26 inhibitors by a hybrid virtual screening approach based on pharmacophore and molecular docking. Biomed Pharmacother. 2017 May;89:376-385.
molnova catalog
related products
  • Dalbavancin

    Dalbavancin(MDL-63397, BI-397) is a novel second-generation lipoglycopeptide antibiotic that exerts its bactericidal effect by disrupting cell wall biosynthesis.

  • Sodium citrate dihyd...

    Sodium citrate dihydrate is an anticoagulant, and also used as a buffer and food preservatives.

  • NITD-349

    NITD-349 is a novel, orally bioavailable mycobacterial membrane protein Large 3 (MmpL3) inhibitor with MIC of 23 nM against M tuberculosis H37Rv.